Vasculitis & polymyalgia rheumatica
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey
Authors' conclusion
This first multinational survey reveals substantial heterogeneity in real-world diagnostic and therapeutic practice, reflecting gaps in validated criteria, standardized activity measures and treatment algorithms.
Study context
- Population
- Experts from experienced European centres within the European eosinophilic granulomatosis with polyangiitis (EGPA) Study Group, six countries
- Participants
- 54 experts6 countries
- Outcome
- Current diagnostic and therapeutic approaches to EGPA
Methodological detailsmultinational expert survey, 44-item online survey, anonymous responses, Survey reviewed by an expert panel; responses collected April–August 2025
- Multinational expert survey
- 44-item online survey
- Anonymous responses
- Survey reviewed by an expert panel; responses collected April–August 2025
Main finding
As reported in the abstract
Histological confirmation reported in
fewer than 25% of cases
Observational data: associations, not effects.
Original publication
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey. Rheumatology (Oxford). Published 21 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →